Contrast study: Comparision of nephroprotective three protocols: Acetylcysteine-sodium bicarbonate-theophylline, to prevent contrast-induced nephropathy


Caglar I. M., TURHAN ÇAĞLAR F. N., Conkbayir C., Baskurt M., AKTÜRK İ. F., Dasli T., ...Daha Fazla

Russian Journal of Cardiology, cilt.105, sa.1, ss.27-31, 2014 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 105 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.15829/1560-4071-2014-1-eng-27-31
  • Dergi Adı: Russian Journal of Cardiology
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.27-31
  • Anahtar Kelimeler: Angiography, Contrast nephropathy
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Aim. The purpose of this study was to compare three prophylactic regimens, sodium-bicarbonate based hydration, sodium-bicarbonate + N-acetylcysteine (NAC), and sodium-bicarbonate + NAC + theophylline, for the prevention of contrast induced nephropathy. Material and methods. We prospectively randomized 151 patients with baseline eGFR values between 30–59 ml/min/1.73m² who were also undergoing coronary angiography with three prophylactic treatments: intravenous hydration with sodium-bicarbonate (3 ml/kg/h for 1 hours before and 1 ml/kg/h for 6 hours after contrast exposure, group 1; n=50), hydration + NAC (600 mg p. o. twice daily the preceding day and the day of angiography, group 2; n=50), and hydration + NAC + theophylline (600 mg p. o. NAC and 200 mg theophylline p. o. twice daily for the preceding day and the day of angiography, group 3; n=51). The incidence of contrast induced nephropathy (0,5 mg/dl increase in serum creatinine from the baseline value 48 hours after intravascular injection of contrast) from the three groups was compared. Results. Of the 151 patients, 4 patients (7.8%) in group 3 experienced CIN (p=0.01). CIN did not develop in group 1 and 2. Conclusion. Among patients with eGFR values between 30–59 ml/min/1.73m² undergoing coronary angiography, use of sodium-bicarbonate based hydration alone and sodium-bicarbonate with NAC was associated with a reduction in the rate of contrast induced nephropathy. Sodium-bicarbonate with theophylline therapy was found to have no effect for the prevention of contrast-induced nephropathy.